NanoViricides, Inc. NNVC
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 936.30K | 744.30K | 1.11M | 803.60K | 938.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.25M | 2.03M | 2.23M | 1.80M | 2.12M |
| Operating Income | -2.25M | -2.03M | -2.23M | -1.80M | -2.12M |
| Income Before Tax | -2.22M | -1.99M | -2.22M | -1.79M | -2.10M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.22M | -1.99M | -2.22M | -1.79M | -2.10M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.22M | -1.99M | -2.22M | -1.79M | -2.10M |
| EBIT | -2.25M | -2.03M | -2.23M | -1.80M | -2.12M |
| EBITDA | -2.12M | -1.90M | -2.10M | -1.66M | -1.95M |
| EPS Basic | -0.10 | -0.09 | -0.11 | -0.10 | -0.13 |
| Normalized Basic EPS | -0.06 | -0.06 | -0.07 | -0.07 | -0.08 |
| EPS Diluted | -0.10 | -0.09 | -0.11 | -0.10 | -0.13 |
| Normalized Diluted EPS | -0.06 | -0.06 | -0.07 | -0.07 | -0.08 |
| Average Basic Shares Outstanding | 22.25M | 21.61M | 19.85M | 17.08M | 16.18M |
| Average Diluted Shares Outstanding | 22.25M | 21.61M | 19.85M | 17.08M | 16.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |